Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2736 (LINC02736) is a long non-coding RNA gene located in an intergenic region that does not encode a protein and does not overlap with annotated coding genes[1][5]. LINC02736, like other lincRNAs, is over 200 nucleotides long and is presumed to regulate gene expression through a variety of mechanisms, including chromatin remodeling, RNA stabilization, and transcriptional regulation in a highly tissue-specific manner[5]. There is no evidence that LINC02736 itself is a direct therapeutic target; its precise biological role remains uncharacterized, and there are no known disease associations, interacting drugs, biomarker utility, or reported safety concerns[1][5].
Not established for this specific lincRNA; generally, lincRNAs can modulate gene expression via interaction with chromatin, transcription factors, or RNA-binding proteins[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2736 (LINC02736).